Join Drs. Doug Devries, Marc Bloomenstein, and Cecelia Koetting as they discuss strategies to manage presbyopes from early to late stages of presbyopia progression. Learn about new and emerging pharmaceutical treatments options as well as next-generation presbyopia-correcting IOLs. 

Agenda:

5:30 – 6:00 PM  Dinner Registration Reception

6:00 – 6:10 PM  Welcome and Introduction (Doug Devries)

6:10 – 6:25 PM  The Early Presbyope: Pharmaceutical Presbyopia Treatments

6:25 – 6:40 PM  The Cataract Patient: Addressing Patient Needs with Next-Generation Presbyopia-Correcting IOLs (Cecelia Koetting)

6:40 – 6:50 PM  Talking to Patients about their Presbyopia Correcting IOL Options (Marc Bloomenstein)

6:50 – 7:12 PM  Case Presentations: Addressing Presbyopia with Latest Technologies (All Faculty)

7:12 – 7:15 PM  Conclusions (Doug Devries)

7:15 – 8:30 PM  Touring of WWII Museum Galleries and Exhibits

Program Learning Objectives:

• Define the prevalence, etiology, and key characteristics of progression of presbyopia from early to late stage patients 
• Outline strategies for finding, communicating with, and educating patients about presbyopia correction clinical outcomes, costs, risks, and benefits, including quality of life and quality of vision considerations
• Describe how the latest presbyopia-correcting IOL technologies, multifocal contact lenses and pharmaceutical presbyopia treatments can address outcomes in a new group of presbyopia patients, including those with comorbid conditions

Supported by an unrestricted educational grant from Johnson & Johnson Vision and Acufocus.

Evolve Medical Education, LLC is a COPE-accredited administrator.
This activity, COPE Activity Number 123429, is accredited by COPE for continuing education for optometrists. 
This course is approved for 1.25 hours CE. 
Course # 76951-PO
Activity # 123429